This content is machine translated Options in the relapse therapy of multiple myeloma. What comes after the first line? Factors such as pretreatment, age, patient performance, and comorbidities determine relapse therapy in multiple myeloma. Triple combinations with a proteasome inhibitor and/or an IMID are standard. Antibody therapies also play…
